Jaydeep Mehta

5PUBLICATIONS
33CO-AUTHORS
Gene and molecular therapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2026
Development of the Weight-Tiered Q3W Regimen of Amivantamab in Combination With Carboplatin-Pemetrexed in EGFR-Mutated Non-Small Cell Lung Cancer.

|Oct 12, 2025
Clinical Pharmacokinetic Assessment of Lazertinib in Healthy Adult Participants: Effects of GSTM1 Genotype.

Jaydeep Mehta, Chuck Thompson, Ellen Scheers

|Sep 09, 2025
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.

James Chih-Hsin Yang, Shun Lu, Hidetoshi Hayashi

|Sep 30, 2023
Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non-Small Cell Lung Cancer.

Nahor Haddish-Berhane, Yaming Su, Alberto Russu

|Jul 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors.

Maria Vieito, Victor Moreno, Anna Spreafico

Pageof 1

Frequent Collaborators

1 joint publications

Maria Vieito

1 joint publications

Victor Moreno

1 joint publications

Anna Spreafico

1 joint publications

Irene Brana